Neoadjuvant chemotherapy improves overall survival in stage III but not in stage II colon cancer: A propensity score-matched analysis of the National Cancer Database

database[Title] 2025-05-13

Summary:

CONCLUSION: Preoperative neoadjuvant chemotherapy is associated with improved overall survival in patients with stage III colon cancer, mainly in patients with T4 disease.

Link:

https://pubmed.ncbi.nlm.nih.gov/40344993/?utm_source=Other&utm_medium=rss&utm_campaign=pubmed-2&utm_content=12QQbiNmM99eUQGIX1JjHIKcROC1Vzv4sOS-2S_LNI19uG_Yrk&fc=20220129225649&ff=20250513220951&v=2.18.0.post9+e462414

From feeds:

📚BioDBS Bibliography » database[Title]

Authors:

Nir Horesh, Sameh Hany Emile, Michael R Freund, Zoe Garoufalia, Rachel Gefen, Peige Zhou, Arun Nagarajan, Steven D Wexner

Date tagged:

05/13/2025, 22:09

Date published:

05/09/2025, 06:00